1. Academic Appointment and Institutional Resources: a. The applicant (MD, PhD, PharmD, or equivalent) must hold an academic faculty appointment and be developing an independent research program. b. The applicant must have obtained an institutional commitment that is sufficient to conduct research and allow the applicant’s long-term success.

2. AST Membership

a. The applicant must be an active member of the AST or have submitted a completed membership application by June 15, 2024.

b. If awarded a grant, the applicant’s membership must be maintained throughout the term of the grant.

3. Other Funding

a. Faculty may only hold one new AST grant per year: as a PI of a concurrent AST grant or as mentor/sponsor of a Fellowship Research Grant. If more than one grant from a given faculty member (as PI or mentor) is submitted and deemed competitive for funding, the AST will determine which grant to fund.

b. Two grants from the same group or from the same institution with significant scientific overlap will not be funded regardless of score. The discretion as to which grant will be funded will be made by the AST Research Network Scientific Review Committee (SRC) at the time of review.

c. The AST Transition to Independence Research Grant project must be distinct from that of any concurrent award. Moreover, this work should not directly overlap with funded projects of other faculty members within the same Section or Department.

d. Applicants who hold a career development grant (e.g., K grant) are eligible to apply.

e. Individuals are ineligible if they are a PI on a previous or current NIH grant to perform independent research (e.g., R01, R35, project PI on a P01 grant, R21, VA Merit award, or comparable non-mentored award).

f. Candidates can apply for an AST grant at the same time as applying for an NIH R01, P01 or any similar independent research award but may not retain AST funding if the other grant is awarded and the funding begins prior to the end of the AST Transition to Independence grant. In such cases, the AST sponsored grant will be rescinded at the time the NIH grant begins.

g. Applicants with concurrent smaller awards and prizes must report these awards, and the application will be adjudicated by the reviewers.

4. Miscellaneous

a. Location: The proposed work is to be performed in a North American research setting. b. Education: The applicant must have an MD, DO, PhD, DVM, PharmD or equivalent graduate degree, and have completed post-graduate training (residencies, post-doctoral fellowships, etc.).

c. Citizenship: The applicant must be either: a) a U.S., Canadian, or Mexican citizen; b) a lawfully admitted permanent resident foreign national of the U.S., Canada, or Mexico with a valid visa during the awarded period; or c) a foreign national admitted lawfully for residence in the U.S., Canada, or Mexico during the awarded period. J1 and H1B visa holders are eligible to apply

Eligible Countries:

Sponsor Institute/Organizations: American Society of Transplantation

Sponsor Type:

Address: 1000 Atrium Way Suite 400 Mt. Laurel, NJ 08054

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.